Har­vard 'MacArthur ge­nius’ Kevin Eggan steps in to run ear­ly-stage re­search at rare dis­ease spe­cial­ist Bio­Marin

Pi­o­neer­ing ALS re­searcher Kevin Eggan has a new gig.

Af­ter hold­ing a tenured po­si­tion at Har­vard while work­ing at the Broad and play­ing a founder …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.